These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31380528)

  • 1. Targeting the Mycobacterium tuberculosis transpeptidase Ldt
    de Munnik M; Lohans CT; Lang PA; Langley GW; Malla TR; Tumber A; Schofield CJ; Brem J
    Chem Commun (Camb); 2019 Aug; 55(69):10214-10217. PubMed ID: 31380528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward antituberculosis drugs: in silico screening of synthetic compounds against Mycobacterium tuberculosisl,d-transpeptidase 2.
    Billones JB; Carrillo MC; Organo VG; Macalino SJ; Sy JB; Emnacen IA; Clavio NA; Concepcion GP
    Drug Des Devel Ther; 2016; 10():1147-57. PubMed ID: 27042006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular insight on the non-covalent interactions between carbapenems and L,D-transpeptidase 2 from Mycobacterium tuberculosis: ONIOM study.
    Ntombela T; Fakhar Z; Ibeji CU; Govender T; Maguire GEM; Lamichhane G; Kruger HG; Honarparvar B
    J Comput Aided Mol Des; 2018 Jun; 32(6):687-701. PubMed ID: 29845435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Fluorescence-Based Assay for Screening β-Lactams Targeting the Mycobacterium tuberculosis Transpeptidase Ldt
    de Munnik M; Lohans CT; Langley GW; Bon C; Brem J; Schofield CJ
    Chembiochem; 2020 Feb; 21(3):368-372. PubMed ID: 31322798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and biochemical analyses of the Ldt
    Wang X; Gu X; Zhang C; Zhao F; Deng K
    Biochem Biophys Res Commun; 2020 Feb; 523(1):6-9. PubMed ID: 31822344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring Covalent Allosteric Inhibition of Antigen 85C from Mycobacterium tuberculosis by Ebselen Derivatives.
    Goins CM; Dajnowicz S; Thanna S; Sucheck SJ; Parks JM; Ronning DR
    ACS Infect Dis; 2017 May; 3(5):378-387. PubMed ID: 28285521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potent L,D-transpeptidase 5 inhibitors for Mycobacterium tuberculosis as potential anti-TB leads: virtual screening and molecular dynamics simulations.
    Sabe VT; Tolufashe GF; Ibeji CU; Maseko SB; Govender T; Maguire GEM; Lamichhane G; Honarparvar B; Kruger HG
    J Mol Model; 2019 Oct; 25(11):328. PubMed ID: 31656981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for the inhibition of Mycobacterium tuberculosis L,D-transpeptidase by meropenem, a drug effective against extensively drug-resistant strains.
    Kim HS; Kim J; Im HN; Yoon JY; An DR; Yoon HJ; Kim JY; Min HK; Kim SJ; Lee JY; Han BW; Suh SW
    Acta Crystallogr D Biol Crystallogr; 2013 Mar; 69(Pt 3):420-31. PubMed ID: 23519417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The selenazal drug ebselen potently inhibits indoleamine 2,3-dioxygenase by targeting enzyme cysteine residues.
    Terentis AC; Freewan M; Sempértegui Plaza TS; Raftery MJ; Stocker R; Thomas SR
    Biochemistry; 2010 Jan; 49(3):591-600. PubMed ID: 20000778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of inhibition of Mycobacterium tuberculosis antigen 85 by ebselen.
    Favrot L; Grzegorzewicz AE; Lajiness DH; Marvin RK; Boucau J; Isailovic D; Jackson M; Ronning DR
    Nat Commun; 2013; 4():2748. PubMed ID: 24193546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of the Mycobacterium tuberculosis antigen 85 complex by covalent, allosteric inhibitors.
    Favrot L; Lajiness DH; Ronning DR
    J Biol Chem; 2014 Sep; 289(36):25031-40. PubMed ID: 25028518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial Activity of Ebselen.
    Maślanka M; Mucha A
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of L,D-transpeptidase LdtMt2 in complex with meropenem reveals the mechanism of carbapenem against Mycobacterium tuberculosis.
    Li WJ; Li DF; Hu YL; Zhang XE; Bi LJ; Wang DC
    Cell Res; 2013 May; 23(5):728-31. PubMed ID: 23588382
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro cross-linking of Mycobacterium tuberculosis peptidoglycan by L,D-transpeptidases and inactivation of these enzymes by carbapenems.
    Cordillot M; Dubée V; Triboulet S; Dubost L; Marie A; Hugonnet JE; Arthur M; Mainardi JL
    Antimicrob Agents Chemother; 2013 Dec; 57(12):5940-5. PubMed ID: 24041897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding and processing of β-lactam antibiotics by the transpeptidase Ldt
    Steiner EM; Schneider G; Schnell R
    FEBS J; 2017 Mar; 284(5):725-741. PubMed ID: 28075068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and crystallographic studies of L,D-transpeptidase 2 from Mycobacterium tuberculosis with its natural monomer substrate.
    de Munnik M; Lang PA; Calvopiña K; Rabe P; Brem J; Schofield CJ
    Commun Biol; 2024 Sep; 7(1):1173. PubMed ID: 39294212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Mycobacterium tuberculosis cytochromes P450: physiology, biochemistry & molecular intervention.
    McLean KJ; Belcher J; Driscoll MD; Fernandez CC; Le Van D; Bui S; Golovanova M; Munro AW
    Future Med Chem; 2010 Aug; 2(8):1339-53. PubMed ID: 21426022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structures of free and inhibited forms of the L,D-transpeptidase LdtMt1 from Mycobacterium tuberculosis.
    Correale S; Ruggiero A; Capparelli R; Pedone E; Berisio R
    Acta Crystallogr D Biol Crystallogr; 2013 Sep; 69(Pt 9):1697-706. PubMed ID: 23999293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Horseradish peroxidase inhibition and antioxidant activity of ebselen and related organoselenium compounds.
    Mishra B; Priyadarsini KI; Mohan H; Mugesh G
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5334-8. PubMed ID: 16919452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening.
    Leroux F; Bosc D; Beghyn T; Hermant P; Warenghem S; Landry V; Pottiez V; Guillaume V; Charton J; Herledan A; Urata S; Liang W; Sheng L; Tang WJ; Deprez B; Deprez-Poulain R
    Eur J Med Chem; 2019 Oct; 179():557-566. PubMed ID: 31276900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.